-
Centralized procurement attacks pharmaceutical companies in all directions to survive in this way
Time of Update: 2022-03-06
Of course, the hospital can also do both Those who are not guilty, kick them all out, and then enter one back through channels such as the Pharmacy Council;For question 3, in the case of multiple companies being selected, after completing the agreed purchase volume, some provinces may differentiate the preferred products based on price, quality level, A and B categories, etc.
-
The prosperity of the domestic CXO industry will continue, but it still faces two major challenges
Time of Update: 2022-03-06
In recent years, the global innovative drug industry has developed rapidly, but new drug R&D has the characteristics of high risk, high investment, and long return period.
-
Xinlitai SAL0114 Tablets Obtained Clinical Trial Approval Notice
Time of Update: 2022-03-06
On February 16, Xinlitai issued an announcement stating that the company received the "Clinical Trial Approval Notice" approved and issued by the State Drug Administration, and agreed to carry out clinical trials of SAL0114 tablets .
-
The policy of Chinese herbal medicines in one place is relaxed, and pharmacies can be exempted from fines of 100,000 yuan
Time of Update: 2022-03-06
The policy of Chinese herbal decoction pieces is relaxed, and pharmacies can be exempted from fines of 100,000 A few days ago, the Jiangsu Food and Drug Administration issued the "Guiding Opinions on the Determination of Jiangsu Province Traditional Chinese Medicine Pieces Do Not Comply with Drug Standards and Does Not Affect Safety and Effectiveness (Trial)" (hereinafter referred to as "Opinions") .
-
Paulno-Sandia names Kent Payne as new CEO
Time of Update: 2022-03-06
Kent M.
In 2019, he first joined Bio-Sandia as President of Global Pharmaceutical Manufacturing Solutions .
Under Kent's leadership, the management team will work in both China and the U.
-
The market of traditional Chinese medicine formula granules will be further expanded, and pharmaceutical companies are rushing to the beach
Time of Update: 2022-03-06
Among them, on February 8, 2022, Jilin Aodong issued an announcement stating that Yanbian Pharmaceutical, a holding subsidiary, received 8 national standard "Chinese Medicine Formula Granules Listing Recording Certificates", including Angelica Formula Granules, Jiu Danshen Formula Granules, etc.
-
As long as it is domestically produced, the results of the 21 million device purchase order will be announced (with a list attached)
Time of Update: 2022-03-06
According to information disclosed by Lingang, the initial investment of the Medtronic Lingang project is about 300 million yuan, which will be used for the research and development and industrialization of cardiovascular disease-related products .
-
Drug balloons may enter the country for centralized procurement, and local pharmaceutical companies are actively deploying
Time of Update: 2022-03-06
Among them, drug balloons have become one of the key varieties of high-value medical consumables centralized procurement.
With the development of centralized procurement, the utilization rate of drug balloons is expected to increase significantly, and the concept of "intervention without implantation" will be further promoted .
-
Medical institutions have not completed the negotiation and acceptance of these drugs and have been closed for purchase!
Time of Update: 2022-03-06
Periodic closure mechanism to clear off the drugs linked to the Internet It is understood that the "full online negotiation" required by Shanghai is directly negotiated by medical institutions designated by medical insurance and drug manufacturers , and the inquiry and negotiation will be implemented in the form of "push information, green line reference, yellow line reminder, and red line interception" .
-
Vancomycin Hydrochloride for Injection by Puli Pharmaceuticals obtained the marketing authorization of the Ministry of Health of Costa Rica
Time of Update: 2022-03-06
It is indicated for penicillin-allergic patients, patients who cannot receive or respond to other drugs (including penicillin or cephalosporins), and infections caused by vancomycin-sensitive organisms that are resistant to other antimicrobials .
-
132 large varieties of Chinese patent medicines are about to open bids
Time of Update: 2022-03-06
Guided by clinical needs, starting from high-priced and large-volume varieties, scientifically and prudently promote the reform of centralized procurement of Chinese patent medicines and formula granules .
-
The path for domestic innovative drugs to go overseas is clearer, and the industry is optimistic about these types of innovative drug companies
Time of Update: 2022-03-06
The agency believes that the ODAC meeting has clarified two new paths for domestic innovative drugs to go overseas in the future: first, the global multi-center clinical trial layout; second, targeting unmet clinical needs in Europe and the United States, or therapies with high scarcity .
-
The 2022 performance of the chain pharmacy giant will usher in an upward turning point!
Time of Update: 2022-03-06
In this regard, the industry predicts that with the continuous expansion of chain pharmacy giants, the industry concentration will continue to increase steadily in the future, and the outflow of prescriptions is expected to accelerate under the resonance of multiple factors.
-
Regular withdrawal of drugs on the Internet has become the norm, and another batch of drugs has been withdrawn from the Internet
Time of Update: 2022-03-06
In fact, since last year, Shanghai has issued a number of online purchase notices, and 18 drugs have been closed for purchase because medical institutions have not completed the negotiation and acceptance .
-
Jitai Pharmaceutical Appoints Academician Chen Hongmin as President and Head of R&D of the US Company
Time of Update: 2022-03-06
Before joining Jitai, Academician Hongmin Chen served as the Chief Scientific Officer of Kala Pharmaceuticals, a biotech company he helped found in 2010 .
Before joining Kala Pharmaceuticals, Academician Hongmin Chen helped found TransForm Pharmaceuticals, which was acquired by Johnson & Johnson in 2005 .
-
Industry: 2022 will become the "Year of Procurement of Traditional Chinese Medicine"
Time of Update: 2022-03-06
At the end of the same year, the “Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine” of the two departments clearly stated that it encouraged the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into the provincial centralized pharmaceutical procurement platform for online transactions to promote open and transparent transactions .
-
Jincheng Pharmaceutical's posaconazole API registration application was approved by CDE
Time of Update: 2022-03-06
On the evening of February 14, Jincheng Pharmaceutical announced that its wholly-owned subsidiary Shandong Jincheng Bio was inquired on the CDE "Original and Auxiliary Package Registration Information" publicity platform and learned that the registration application for "posaconazole" API submitted by it was approved by the CDE.
-
Huang Xiaodong, Deputy General Manager and Secretary of the Board of Directors of Fuxiang Pharmaceutical, resigned
Time of Update: 2022-03-06
On the evening of February 14, Fuxiang Pharmaceutical announced that Huang Xiaodong resigned from the company's deputy general manager and board secretary due to personal reasons, and would no longer hold any positions in the company after his resignation .
-
In Q3 2021, the sales of two blockbuster monoclonal antibodies exceeded 5 billion yuan
Time of Update: 2022-03-06
However, from the perspective of the market structure, the current domestic bevacizumab injection market is mainly divided by the original researcher Roche and Qilu Pharmaceutical .
. However, with the entry of domestic pharmaceutical companies, the industry expects that the Roche bevacizumab injection market will be impacted in the future.
-
210 drug reviews!
Time of Update: 2022-03-06
According to the notice, 210 products were reviewed and purchased online, of which 122 pharmaceutical companies including Amoxicillin Capsules of Yuekang Pharmaceutical Group, Omeprazole Enteric-Coated Tablets of Fangsheng Pharmaceutical, Bicalutamide Tablets of Jianghaizheng Pharmaceutical, Linezolid Glucose Injection of Chia Tai Tianqing Pharmaceutical Group 's products .
